Clinical & Diagnostics
Butterfly Network Wins First-Ever FDA Clearance for Blind-Sweep AI Gestational Age Ultrasound Tool
Butterfly's Gestational Age Tool received FDA 510(k) clearance on March 30, 2026, becoming the first cleared blind-sweep ultrasound AI in the U.S. The model was trained on more than 21 million images across diverse demographics and delivers biometry-equivalent gestational age assessments for patients between 16 and 37 weeks — matching sonographer accuracy. The three-step workflow (enter fundal height, apply gel, perform guided sweeps) requires no screen interpretation by the user. Backed by the Bill & Melinda Gates Foundation, the tool is already deployed in Malawi and Uganda; U.S. clearance now enables rural expansion at scale.
Aidoc Secures FDA Clearance for Healthcare's First Comprehensive Foundation Model AI — Triaging 14 Acute Conditions from One Model
Aidoc's CARE™ foundation model received FDA clearance covering 11 newly cleared acute indications plus three previously cleared ones, all running on a single abdominal CT AI architecture. The pivotal study reported mean sensitivity of 97% and mean specificity of 98% across the 11 new indications — with performance up to 98.5% sensitivity and 99.7% specificity on individual findings. The system delivers roughly an order-of-magnitude reduction in false alerts compared to best-in-class single-condition solutions, and the CARE roadmap includes planned expansion to all CT and X-ray workflows within 18 months.
Athenahealth Rolls Out AI-Native EHR Platform and Launches Ambient Scribe for 100,000+ Providers
The AI-native athenaOne platform refresh includes athenaAmbient (in testing since February 2026), AI-enhanced document services, intelligent clinical summaries, and improved interoperability tooling. Athenahealth also became the first healthcare IT company to implement TEFCA at scale across all eligible providers in its 160,000-strong network. The company is piloting a Model Context Protocol (MCP) server for athenaOne — claimed as a first for the industry — enabling AI models to communicate directly with EHR data without custom integration work.
Research & Science
Merck and Mayo Clinic Form Landmark AI Drug Discovery Partnership, Opening Access to Genomic and Multimodal Clinical Data
The partnership gives Merck access to Mayo Clinic Platform Orchestrate, a secure multimodal repository spanning genomic sequences, clinical records, imaging, and biorepositories. Merck will deploy AI-enabled virtual cell technologies to model disease biology, improve target identification, and accelerate early-stage development decisions. The collaboration integrates Merck's ML research capabilities with Mayo's Platform architecture, targeting three high-need therapeutic areas initially, with the intent to generate in silico biological insights before wet-lab validation begins.
Stanford-Harvard ARISE Report: Clinical AI Has Boomed — But Top Models Still Make Severe Errors in 12–15% of Cases
The ARISE (AI Research and Science Evaluation) network synthesized the most influential clinical AI studies published in 2025 across Stanford, Harvard, and affiliated health systems. Key quantitative finding: top-performing AI models made between 12 and 15 severe errors per 100 clinical cases; worst-performing systems exceeded 40 severe errors per 100 cases. The report identifies brittleness in uncertainty estimation — models fail to recognize when they don't know — as the most persistent systemic risk in current clinical deployment. Full report available at arise-ai.org/report.
Nature Study: Deep Learning Fuses Pathology and Radiology Into a Single AI-Assisted Diagnostic System
The paper presents a deep learning image classification framework that integrates pathology's cellular morphology analysis with radiology's anatomical and functional imaging into a multimodal pipeline. The system uses cross-modal attention mechanisms to combine spatial features from histological slides and volumetric scan data, with validation across oncology use cases demonstrating statistically significant improvement in diagnostic accuracy versus single-modality baselines. The work addresses a key bottleneck in clinical AI: most existing tools operate on one data type in isolation, missing complementary diagnostic signals.
Policy & Regulation
WHO Calls Generative AI a Public Mental Health Concern, Releases Responsible AI Framework for Mental Health Tools
The guidance emerged from a January 29, 2026 expert workshop convening over 30 international specialists in AI, mental health, ethics, and public policy. Three core recommendations: (1) classify GenAI's mental health impact as a public health concern requiring government response; (2) integrate mental health impact assessments into AI product monitoring, with specific attention to emotional dependence and long-term outcomes; (3) mandate co-design of mental health AI tools with clinical experts and people with lived experience. WHO is simultaneously establishing a global Consortium of Collaborating Centres on AI for Health spanning all six WHO regions.
TEFCA Hits 500 Million Health Records Exchanged — A 4,900% Jump in 12 Months
The Trusted Exchange Framework and Common Agreement (TEFCA) — a government-backed, FHIR-enabled interoperability initiative — processed nearly 500 million record exchanges, representing a 4,900% increase since January 2025. HHS projects over $19.2 billion in administrative cost savings over the next decade from health IT regulations enabling electronic prior authorizations. Simultaneously, ASTP/ONC released the draft USCDI v7 proposing 29 new standardized data elements, and $20+ million was committed to nine Behavioral Health IT pilot programs integrating SAMHSA data into TEFCA-compatible workflows.
FDA Cuts Red Tape on Clinical Decision Support Software, Allowing Single-Recommendation AI Tools to Bypass Review
The FDA's revised CDS guidance removes the requirement that single-recommendation software — previously considered "non-device" only when clinicians could independently review and understand the basis of recommendations — must undergo 510(k) clearance. This follows CPT 2026's inclusion of 288 new codes covering digital health and AI services, and CMS expansion of payment policies for digital mental health treatment devices. The policy shift is concurrent with an overall FDA posture toward lighter-touch regulation of wearables and AI-enabled devices announced in January 2026.
Industry & Business
Jimini Health Raises $17M for Sage — A Clinician-Supervised AI Behavioral Health Chatbot
The $17M round was led by M13, with participation from Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind, bringing Jimini's total capital to over $25M. Sage is trained to follow individualized care plans written by human clinicians — it does not improvise responses — and clinicians retain full access to all patient-Sage conversation logs, with automated alerts triggering when the system detects deterioration. Jimini plans to use the funding to scale EHR integrations and expand partnerships with behavioral health organizations.
Qualified Health Raises $125M Series B to Operationalize Enterprise AI Across 500,000+ Health System Users
The Series B was led by NEA, with participation from Transformation Capital, GreatPoint Ventures, Cathay Innovation, and Menlo Ventures' Anthology Fund (an Anthropic-partnership AI fund). Qualified Health's platform provides enterprise AI governance infrastructure — safety guardrails, compliance tooling, and deployment pipelines — designed for health systems that need to deploy and manage multiple AI models simultaneously. Current customers include Mercy, Emory Healthcare, University of Rochester Medicine, Jefferson Health, and all eight University of Texas System health institutions. Funds will be directed to product engineering and expanded clinical AI capabilities.
Doctronic Raises $40M After Becoming First AI Platform Legally Authorized to Renew Prescriptions in the U.S.
Doctronic's Series B was led by Abstract and Lightspeed Venture Partners, bringing total capital raised to $65M across three rounds in under a year. The platform's core architecture pairs an AI chatbot for symptom intake with telehealth physician handoffs for diagnosis — handling 15 million+ medical conversations with 1 million+ users, and serving 300,000 unique weekly visitors. Since its $20M Series A in September 2025, the company reported 15x revenue growth to 8-figure annualized revenue. Utah's January 2026 autonomous prescription renewal partnership represents the first state-level regulatory authorization for AI prescribing in U.S. history. Expansion into pediatrics is the stated next priority.
J.P. Morgan: AI Now Drives 75% of All Health Tech Deals, Commanding an 83% Funding Premium Over Non-AI Startups
J.P. Morgan's 2026 health technology report found that AI-focused deals now constitute 75% of all health tech transactions, with AI-enabled healthcare startups capturing 62% of all digital health venture funding in the U.S. in the first half of 2025. AI startups raised an average of $34.4M per round — an 83% premium over non-AI digital health rounds. Series B rounds represent 60% of AI-related transaction volume, and the global healthcare AI market is projected to reach $45.2 billion by end of 2026.
Social Buzz
Viral Op-Ed: "Healthcare's AI Obsession Is Missing the Point on Nursing Shortages" — MedCity News
The op-ed lands in a context where the U.S. faces a deficit of over 250,000 registered nurses, and more than 65% of hospitals have run below full capacity due to staffing shortages. Critics of the AI-first approach note that while tools like predictive burnout modeling, virtual nursing, and robotics (e.g., Nurabot from Foxconn, Moxi from Diligent Robotics) reduce non-medical workload, they do not address the systemic drivers of nurse attrition: pay, conditions, and staffing ratios. The debate has intensified as vendor claims about AI "solving" staffing have multiplied.
Patients Are Using ChatGPT to Decode Medical Bills, Catch Overcharges, and Win Insurance Appeals
OpenAI's ChatGPT has added health insurance navigation features targeting ACA enrollment, coverage explanations, and billing dispute support. Users share itemized bills as structured PDFs or images, and the model identifies anomalies by cross-referencing CPT codes, payer policies, and Medicare fee schedules embedded in its training data. The workflow has evolved from curiosity to a repeatable patient strategy: upload bill → flag suspicious line items → draft appeal letter → submit. Healthcare policy observers note that widespread AI-assisted appeals could create systemic pressure on payer billing practices.
STAT: "Who'll Pay for AI in Healthcare?" Is the Question Nobody Has Answered Yet
The piece identifies three structural payment trends to watch in 2026: (1) CMS CPT code expansion — 288 new codes now cover AI-assisted services, but reimbursement rates remain too low for most vendors to build sustainable businesses; (2) payer cost-sharing models, where AI that demonstrably reduces total cost of care might be paid for by insurers rather than providers; (3) direct-to-employer AI health benefits, where self-insured employers pay for AI tools as part of benefit packages. The reimbursement gap has grown into healthcare AI's biggest structural headwind, with venture investors increasingly scrutinizing "who pays" before funding Series A rounds.